Overcoming The Challenges Of Developing Hearing Loss Therapies

Numerous New Tests And Better Biomarkers Of Hearing Loss Have Yet To Be Clinically Validated

Hearing loss remains an area in dire need of new treatments, and while new approaches such as regenerative and gene therapies are under development, running clinical trials involves a number of challenges, according to speakers at a UK webinar.

Hearing Loss
• Source: Shutterstock

Hearing loss is the most common sensory disorder in humans, and one that will probably affect most of us to some extent at some point in our lives. The usual cause of the condition is the progressive loss of inner ear sensory hair cells and synapses caused by aging, although numerous other factors may be at play, such as genetic predisposition, infections and ototoxic medicines.

Yet hearing loss remains an area of significant unmet clinical need. Current approaches mostly involve hearing devices that rely on...

More from Innovation

More from In Vivo